These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33327492)

  • 1. Molecular Features and Clinical Management of Hereditary Gynecological Cancers.
    Ueki A; Hirasawa A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
    Sorscher S; Ansley K; Delaney SD; Ramkissoon S
    Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary gynecologic tumors and precision cancer medicine.
    Ogawa C; Hirasawa A; Ida N; Nakamura K; Masuyama H
    J Obstet Gynaecol Res; 2022 May; 48(5):1076-1090. PubMed ID: 35229413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk and gynecologic cancers.
    Holman LL; Lu KH
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):13-29. PubMed ID: 22244659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.
    Saam J; Arnell C; Theisen A; Moyes K; Marino I; Roundy KM; Wenstrup RJ
    Oncology; 2015; 89(5):288-93. PubMed ID: 26315041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome.
    Agarwal R; Liebe S; Turski ML; Vidwans SJ; Janku F; Garrido-Laguna I; Munoz J; Schwab R; Rodon J; Kurzrock R; Subbiah V;
    Discov Med; 2014 Dec; 18(101):331-9. PubMed ID: 25549704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heritable Gastrointestinal Cancer Syndromes.
    Stoffel EM
    Gastroenterol Clin North Am; 2016 Sep; 45(3):509-27. PubMed ID: 27546846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Landscape of somatic mutated genes and inherited susceptibility genes in gynecological cancer.
    Watanabe T; Soeda S; Okoshi C; Fukuda T; Yasuda S; Fujimori K
    J Obstet Gynaecol Res; 2023 Nov; 49(11):2629-2643. PubMed ID: 37632362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynecological lesions in hereditary cancer predisposition syndromes.
    Dundr P; Cibula D; Foretová L; Macek M; Kopečková K; Petruželka L; Němejcová K; Bártů M; Hojný J; Hájková N; Jakša R; Janega P; Stružinská I
    Cesk Patol; 2021; 57(2):96-104. PubMed ID: 34275319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil.
    Cipriano NM; de Brito AM; de Oliveira ES; de Faria FC; Lemos S; Rodrigues AN; de Oliveira Lopes D; Dos Santos LL
    Breast Cancer; 2019 May; 26(3):397-405. PubMed ID: 30535581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare Hereditary Gynecological Cancer Syndromes.
    Watanabe T; Soeda S; Endo Y; Okabe C; Sato T; Kamo N; Ueda M; Kojima M; Furukawa S; Nishigori H; Takahashi T; Fujimori K
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary ovarian cancer: not only BRCA 1 and 2 genes.
    Toss A; Tomasello C; Razzaboni E; Contu G; Grandi G; Cagnacci A; Schilder RJ; Cortesi L
    Biomed Res Int; 2015; 2015():341723. PubMed ID: 26075229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
    Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
    Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy.
    Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE
    Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal genetic counseling practices regarding recommendations for cancer genetic counseling: A retrospective chart review from two academic institutions.
    Saba LF; Sullivan CM; Solomon T; Huguenard S; Nassef SA
    J Genet Couns; 2022 Oct; 31(5):1062-1070. PubMed ID: 35434961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Predisposition for Gynecologic Cancers.
    González Peña T; Huang M
    Clin Obstet Gynecol; 2024 Dec; 67(4):660-665. PubMed ID: 39371029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for cancer predisposition.
    Eng C; Hampel H; de la Chapelle A
    Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.